Blueberry Therapeutics Ltd is delighted to have joined the BEAM Alliance (Biopharmaceutical companies from Europe in Anti-Microbial resistance). The BEAM Alliance aims to raise awareness on the very specific issues that small and medium European biopharmaceutical companies are facing when developing and bringing to market innovative products to address antimicrobial resistance.

More information about the BEAM Alliance can be found here: